chengyewang/TexOCR-eval huggingface dataset:
application sets respectively. In particular, employing a reduced set of templates for template selection leads to an average area reduction of over 27\%.

Finally, Table~\ref{tab:table_3} reports on the efficiency that is obtained when the reduced set of templates and the full set of templates are used for template selection. The efficiency is calculated as shown in (8), where $ESCS$ is the Effective Software Cycle Savings which accounts for the hardware execution delay of the custom instructions $p_i$ ($T_c(p_i)$), where $i = 1, \ldots, n$, and is calculated as shown in (9). $T_c(p_i)$ is obtained by calculating the number of clusters in the critical path of the custom instructions. For example, $T_c$ of the custom instruction in Figure~\ref{fig:figure_4}(a) is 2. Note that we have assumed that the delay of each cluster is equivalent to two software clock cycle executions. This is a reasonable assumption as the FPGA logic can generally execute at a significantly higher clock frequency than a commercially available soft processor core which is implemented on the same fabric~\cite{55}.

\begin{equation}
Efficiency = \frac{ESCS}{A_{RFU}^{K}}
\tag{8}
\end{equation}

\begin{equation}
ESCS = \sum_{i=1}^{n} F(p_i) \times (T_{sw}(p_i) - 2 \cdot T_c(p_i))
\tag{9}
\end{equation}

\begin{table}[h]
\centering
\begin{tabular}{lccc|ccc}
Domain & \multicolumn{3}{c|}{Reduced Templates} & \multicolumn{3}{c}{Full Templates} \\
 & ESCS & Area & Efficiency & ESCS & Area & Efficiency \\
Automotive-Industrial & 14664576 & 45182539.6 & 0.325 & 14814576 & 64546485.15 & 0.230 \\
Image & 1538018 & 364687641.1 & 0.004 & 1559449 & 416324829.2 & 0.004 \\
Network & 102859967 & 64546485.15 & 1.594 & 129603704 & 80683106.43 & 1.606 \\
Security & 19207719 & 142002267.3 & 0.135 & 22467162 & 264640589.1 & 0.085 \\
Telecomm & 5823638 & 41955215.34 & 0.139 & 6873517 & 71001133.66 & 0.097 \\
Generic & 146359636 & 635782878.68 & 0.230 & 176180091 & 761648524.7 & 0.231 \\
\end{tabular}
\caption{Comparing the efficiency when reduced set and full set of templates are used for template selection}
\label{tab:table_3}
\end{table}

It can be observed in Table~\ref{tab:table_3} that the efficiency of the proposed method is higher than the case when the full set of templates is used in a number of application domains (with comparable results in the remaining domains). In particular, the average efficiency gain when a reduced set of templates is used is over 25\%.
\begin{table}[htbp]
\centering
\caption{Clinical Trials of Pre-Exposure Prophylaxis}
\label{table_4}
\begin{tabular}{|l|p{4cm}|p{3cm}|p{3cm}|p{3.5cm}|p{4cm}|}
\hline
Trial & Study Population & Location & Intervention & Outcome & Comments \\
\hline
TDF2 & 1,219 sexually active adults; 55\% male, 45\% female; 94\% unmarried; approximately 90\% aged 21--29 & Botswana & Daily oral TDF/FTC & 63\% protection & $>$30\% did not complete study; cannot draw definitive conclusions for women and men separately. \\
\hline
PIP & 4,758 serodiscordant heterosexual couples; 38\% HIV-negative female partner, 68\% HIV-negative male partner; 98\% married; median age 33 & Botswana, Kenya, Rwanda, South Africa, Tanzania, Uganda, Zambia & Daily oral TDF or TDF/FTC & 67\% protection with TDF alone; 75\% protection with TDF/FTC & Serodiscordant couples may be a distinct, unique population. \\
\hline
FEM-PrEP & 1,951 heterosexual women aged 18--35 at high risk of infection & Kenya, South Africa, Tanzania & Daily oral TDF/FTC & Trial discontinued for futility in April 2011. & Adherence assessment with monthly clinical samples to measure drug concentration is pending. \\
\hline
VOICE MTN-003 & 5,029 heterosexual women aged 18--45 in high-prevalence areas & Uganda, South Africa, Zimbabwe & Daily oral TDF or daily oral TDF/FTC or daily topical TFV gel & No study drug significantly reduced the risk of HIV acquisition. Estimates of effectiveness were less than 0 for TDF and TDF/FTC daily oral dosing (negative 48.8\% and negative 4.2\% TDF/FTC respectively), and reduced risk of HIV infection of 14.7\% for TDF gel. & Adherence to study drugs was low; TFV was detected in 30\% of the oral TDF arm, 29\% in the oral TDF/FTC arm, and 25\% in the TDF gel arm. \\
\hline
\end{tabular}
\end{table}

Key to Acronyms: FTC = emtricitabine; TDF = tenofovir disoproxil fumarate; TFV = tenofovir.

Source: Adapted from: Kashuba et al., Pre-exposure prophylaxis for HIV prevention: how to predict success: Table Antiretroviral-based HIV prevention studies. \textit{Lancet}. 2012;379(9835): 2409--2411.
\section{Current status of retention and graduation rates}

\begin{table}[h]
\centering
\begin{tabular}{lccc}
Year & 17-18 & 16-17 & 15-16 \\
New Freshmen & 79.3\% & 80.8\% & 78.9\% \\
New Transfers & 82.0\% & 80.6\% & 81.7\% \\
New Incoming & 79.7\% & 80.8\% & 80.2\% \\
\end{tabular}
\label{table_1}
\end{table}
\title{Customer Standing Committee (CSC) Meeting 68}

22 February 2022 \\ 
10.00 - 11.00 UTC

\section*{Agenda and Notes}

\section{Welcome \& Roll Call}
Meeting is quorate \\ 
Apologies Holly

\section{Action Items}

\begin{table}[h]
\centering
\begin{tabular}{|l|p{9cm}|l|}
\hline
Action Items & Description & Status \\
\hline
Action item 01 67 2022 & Staff to circulate Findings November to CSC for approval & Completed \\
\hline
Action item 02 66 2022 & Brett, Frederico and staff to prepare table top exercise and inform CSC on progress at next meeting & Completed \\
\hline
Action item 03 66 2022 & Amy to check with Marilia if results IANA survey can be presented during meeting 68 & Completed, see item 4. \\
\hline
Action item 03 65 2022 & Staff to schedule Table Top exercise RAP for future meeting & Pending, March meeting (in person). \\
\hline
Action item 06 65 2022 & Staff to organize session discussing the results of IANA survey March/April meeting & Completed see action item 03 67 and agenda item 4 \\
\hline
\end{tabular}
\label{table_1}
\end{table}

All Actions completed

\section{Performance IANA Naming Function January 2023}
\subsection{PTI report to CSC January 2023}
SLA missed 98,6\%. DDoS attack, which impacted whois. Discussion on mitigation of future attacks. Noted that likely that attack was not directed at IANA, was caught up in traffic. CSC expressed willingness to provide assistance, if helpful. No further action required. Issue was satisfactory explained. This will be reflected in CSC Finding report.

\subsection{CSC Findings PTI Performance January 2023}
CSC Findings report reflects PTI performance was satisfactory over January 2023. Missed SLA was satisfactory explained.

Action 01 68 2023 -- staff to circulate CSC Findings

\section{Presentation results PTI's IANA Naming Function survey}
The presentation is deferred to April at request PTI

Action 02 68 2023: staff to include presentation on April Agenda

\section{Chair and vice-chair nomination (to be completed March 2023)}
Brett and Frederico were appointed as chair and vice-chair by 1 October 2022. The regular term starts at the meeting coinciding with the Community Forum ICANN meeting, to allow members and liaisons, who took their position in October of the preceding year to participate meaningful in the selection process. At this meeting the nomination opens.
Judgment for Claimant (in default)

To [Claimant][Defendant][’s solicitor]

Malabu Oil \& Gas Limited\\
A company Incorporated under the\\
Laws of the Federal Republic of\\
Nigeria\\
35 Kingsway Road\\
Ikoyi\\
Lagos\\
Nigeria

In the ADMIRALITY AND COMMERCIAL COURT

Claim No. CL-2016-000631

Claimant (including ref.) The Federal Republic of Nigeria

Defendant (including ref.) Malabu Oil \& Gas Limited

Date

To the Defendant

You have not replied to the claim form

It is therefore ordered that you must pay the claimant the balance in the USD denominated supreme court account (of \$85,000,000 which at today’s rate of exchange being 0.79 to one GBP converts to GBP equivalent of £66,619,087.05 together with any interest which has accrued on that amount) and £10,185 for costs forthwith.

If you ignore this order your goods may be removed and sold, or other enforcement proceedings may be taken against you. If this happens further costs will be added. If your circumstances change and you cannot pay, ask at the court office what you can do.

Notes for the defendant

If you did reply to the claim form and believe judgment has been entered wrongly in default, you may apply to the court office giving your reasons why the judgment should be set aside. An application form is available for you to use and you will need to pay a fee. A hearing may be arranged and you will be told when and where it will take place. If you live in, or your solicitor’s business is in, another court’s area, the claim may be transferred to that court.

You can ask the court to cancel the entry on the Register. You will need to give proof of payment. You can (for a fee) also obtain a Certificate of Cancellation from the court. If you pay the debt in full after one month you can ask the court to mark the entry on the Register as satisfied and (for a fee) obtain a Certificate of Satisfaction to prove that the debt has been paid.

If the judgment is for £5,000 or more, or is in respect of a debt which attracts contractual or statutory interest for late payment, the claimant may be entitled to further interest.
\section{VII. TRYB I SPOSÓB WPISYWANIA KONI DO KSIĄG KONI RASY POLSKI KOŃ ZIMNOKRWISTY}

\subsection*{§ 1}

\begin{enumerate}
\item Prowadzący księgę powołuje 5-osobową Komisję Księgi Stadnej koni rasy polski koń zimnokrwisty. Komisja reprezentuje hodowców koni tej rasy. W jej skład powołuje się uznane autorytety z dziedziny hodowli i użytkowania koni rasy zimnokrwistej. Do ważności podejmowanych przez Komisję decyzji wymagana jest obecność przynajmniej trzech jej członków, w tym jej przewodniczącego.

Zadaniem Komisji jest:
\begin{enumerate}
\item kontrolowanie prawidłowości wpisu koni do ksiąg i rozstrzyganie spornych kwestii,
\item wydawanie decyzji o wpisaniu ogiera do księgi,
\item kontrolowanie i ocena efektywności działania programu hodowlanego,
\item w miarę potrzeb wnioskowanie do ministra rolnictwa o wprowadzanie zmian w programie hodowlanym.
\end{enumerate}

\item Wpisu koni do ksiąg dokonuje specjalista upoważniony przez prowadzącego księgę.

\item Wpisu ogierów i klaczy do ksiąg dokonuje się na pisemny wniosek hodowcy.

\item Wnioski o dopuszczenie ogierów (bądź ich nasienia) do użycia w rasie polski koń zimnokrwisty należy składać przed sezonem kopulacyjnym, najpóźniej do 30 listopada. Wnioski złożone po tym terminie będą rozpatrywane po pokryciu przez właściciela kosztów pracy komisji księgi stadnej.

\item Przed wpisaniem konia do księgi należy:
\begin{enumerate}
\item sprawdzić tożsamość konia (identyfikacja) przez porównanie zgodności danych zawartych w paszporcie konia, szczególnie opisu umaszczenia, odmian, wieku oraz innych znaków identyfikacyjnych ze stanem faktycznym. Opis maści i odmian powinien być przeprowadzony przed odsadzeniem źrebięcia od matki. Dla celów identyfikacji konie mogą być znakowane za pomocą elektronicznych nośników informacji (czipów);

\item sprawdzić prawidłowość rozwoju konia i stwierdzić brak objawów chorobowych -- w przypadku zaistnienia wątpliwości można zażądać świadectwa lekarza weterynarii;

\item wykonać podstawowe pomiary konia (wysokość w kłębie, obwód klatki piersiowej, obwód nadpęcia);

\item przeprowadzić ocenę pokroju wg skali 100-punktowej, przyznając za:
\begin{itemize}
\item typ \dotfill do 15 pkt.
\item głowę i szyję \dotfill do 5 pkt.
\item kłodę \dotfill do 15 pkt.
\item kończyny przednie \dotfill do 10 pkt.
\item kończyny tylne \dotfill do 10 pkt.
\item kopyta \dotfill do 10 pkt.
\end{itemize}
\end{enumerate}

\end{enumerate}
\begin{figure}
\centering
\includegraphics{figure_2.pdf}
\caption{Figure 2. Continued}
\label{figure_2}
\end{figure}

Table S3).\cite{48,49} A second trial reported a positive and significant correlation between high CD4\% and antibody titers but did not provide stratified estimates\cite{54} whereas a third trial found no difference in antibody titers by CD4\% nadir\cite{} (Supplement Figure S6A--D). Finally, a fourth trial reported higher seropositivity rates and antibody titers in PLHIV on ART than not on ART\cite{52,53} while another one reported higher antibody titers for all four HPV vaccine types among PLHIV virally suppressed compared to non-suppressed.\cite{55}

\subsection{Biological endpoints}
Results on various biological outcomes among PLHIV following vaccination were available from two RCTs with placebo arms,\cite{56,57} one RCT comparing the bivalent and quadrivalent vaccine,\cite{31} two trials with historical controls\cite{4,6,58} and three single arm trials without control,\cite{32,49,59} Studies were conducted among women (N=2), men (N=3), or both (N=3), and among study participants HPV negative at baseline (N=7) or with unknown baseline HPV status (N=3). (Supplement Table S6; additional details in S7). No results were available for children. No results by HIV disease stage or ART status were available. Estimates of biological outcomes were generally deemed of low quality following our study quality assessment. Main study limitations included failure to specify the HPV vaccine type present in abnormal cytology samples, define baseline HPV
\title{AJAX CLEANER POWER-OXYGEN BLEACH}
\author{Colgate-Palmolive Co.}

\section{Product and Company Identification}

\textbf{Product name}: AJAX CLEANER POWER-OXYGEN BLEACH

\textbf{MSDS Number}: 200000017621

\textbf{CAS-No.}: Not applicable - product is a mixture

\textbf{General Use}: A formulated multi-purpose cleaner.

\textbf{Company}: Colgate-Palmolive Co \\
Commercial Consumer Group \\
191 East Hanover Avenue \\
Morristown, NJ 07960-3151

\textbf{Emergency telephone}: For emergency involving spill, leak, fire, exposure or accident, call CHEMTREC (800)424-9300, day or night.

\textbf{Medical Emergency (24HR)}: For MEDICAL EMERGENCIES involving this product call: (888) 489-3861

\section{Hazards Identification}

\subsection{Emergency Overview}

\textbf{Form}: Powder

\textbf{Appearance}: Off-white

\subsection{Potential Health Effects}

\textbf{Eye contact}: Causes eye irritation on direct contact.

\textbf{Skin contact}: May cause skin irritation upon prolonged contact.

\textbf{Inhalation}: No adverse effects due to inhalation are expected.

\textbf{Ingestion}: May be harmful if swallowed in large quantities.

\section{Composition/Information on Ingredients}

\subsection{Hazardous components}

OSHA-REGULATED COMPONENTS (present at a concentration of >= 1\%)

\begin{table}[h]
\centering
\begin{tabular}{lll}
\hline
Chemical Name & CAS-No. & Concentration \\
\hline
LIMESTONE & 1317-65-3 & 60.00 -- 100.00 \\
SODIUM CARBONATE & 497-19-8 & 5.00 -- 10.00 \\
SODIUM DODECYL BENZENE SULFONATE & 25155-30-0 & 1.00 -- 5.00 \\
\hline
\end{tabular}
\label{table_1}
\end{table}

All concentrations are present by weight unless ingredient is a gas. Gas concentrations are in percent by volume.
\begin{table}
\caption{Previous and current status of \textit{A. desertorum} in Indian desert.}
\label{table_1}
\begin{tabular}{|l|l|l|}
\hline
\multicolumn{2}{|c|}{Occurrence localities reported in previous work} & Occurrence localities reported during current work \\
\hline
Occurrence locality & Authors & Current status reported during field survey 2016--2020 \\
\hline
Mandore, Jodhpur & Bhandari, 203, 294,1293 (JAC) & Not present \\
Devikot, Jaisalmer & Blatter \& Hallberg, 3341 (BLAT); Tiwari 867 (BSJO) & Not present \\
Vinjorai, Jaisalmer & Blatter \& Hallberg, 3344 (BLAT) & Not present \\
Kotda, Jodhpur & Blatter \& Hallberg, 3345 (BLAT) & Not present \\
Badka, Jodhpur & Blatter \& Hallberg, 3346, 3347 (BLAT) & Not present \\
Not reported & Not reported & Akal wood fossil park, Jaisalmer \\
\hline
\end{tabular}
\end{table}

\begin{table}
\caption{Sheet of IUCN Criteria-A.}
\label{table_2}
\begin{tabular}{|l|c|c|c|}
\hline
Use of the criteria A & Critically Endangered & Endangered & Vulnerable \\
\hline
A. Population reduction & \multicolumn{3}{c|}{Declines measured over the longer of 10 years or 3 generations} \\
\hline
A1 & $\geq$ 90\% & $\geq$ 70\% & $\geq$ 50\% \\
A2, A3 \& A4 & $\geq$ 80\% $\checkmark$ & $\geq$ 50\% & $\geq$ 30\% \\
\hline
\multicolumn{4}{|l|}{A2: Population reduction observed, estimated, inferred, or suspected in the past where the causes of reduction may not have ceased OR may not be understood OR may not be reversible, based on and specifying any of the following} \\
\hline
 & Tick right sign. & others &  \\
\hline
(a) direct observation & $\checkmark$ &  &  \\
(b) an index of abundance appropriate to the taxon & X &  &  \\
(c) a decline in area of occupancy (AOO), extent of occurrence (EOO) and/or habitat quality & $\checkmark$ &  &  \\
(d) actual or potential levels of exploitation & X &  &  \\
(e) effects of introduced taxa, hybridization, pathogens, pollutants, competitors or parasites & X &  &  \\
\hline
\multicolumn{4}{|c|}{IUCN Assessment CR/A2ac} \\
\hline
\end{tabular}
\end{table}

\begin{table}
\caption{Sheet of IUCN Criteria-B}
\label{table_3}
\begin{tabular}{|l|c|c|c|}
\hline
Use of the criteria B & Critically Endangered & Endangered & Vulnerable \\
\hline
B. Geographic range & \multicolumn{3}{c|}{Geographic range in the form of either B1 (extent of occurrence) AND/OR B2 (area of occupancy)} \\
\hline
B1. Extent of occurrence (EOO) & $<$ 100 km$^2$ & $<$ 5,000 km$^2$ & $<$ 20,000 km$^2$ \\
B2. Area of occupancy (AOO) & $<$ 10 km$^2$ $\checkmark$ & $<$ 500 km$^2$ & $<$ 2,000 km$^2$ \\
B1 OR B2. (a) Severely fragmented, OR Number of locations & = 1 $\checkmark$ & $\leq$ 5 & $\leq$ 10 \\
\hline
\end{tabular}
\end{table}
\section{Daily Events}

\subsection{Monday}
\textbf{AM:}

\textbf{PM:} History, Physical Examination, and Restraint Laboratory: Head \& neck, bovine. Instructors: Semrad, Riesberg, and Goodger.

Herd Health Management (623-675): Crew Chief: 2nd yr (Rebecca Morris), 1st yr (Travis Kuhlka), pre-vet (Allison Wistrand).

\subsection{Tuesday}
\textbf{AM:} 4th year Theriogenology rotation (623-699) herd check: Harry Momont/Bill Bosu, 4th yr. students, \& pre-vet Kerry Hagen.

Bleeding opportunity to tail bleed cows for Chuck Czuprynski's laboratory.

\textbf{PM:} Herd Health Management (623-675): Crew Chief: 2nd yr (Rebecca Morris), 1st yr (Travis Kuhlka), pre-vet (Allison Wistrand).

\subsection{Wednesday}
\textbf{AM:} LAIM (a.k.a. Laura Lien) will be sending a 4th year student to tail bleed for Chuck Czuprynski's lab and laboratory and exam any sick cows.

\textbf{PM:} Herd Health Management (623-675): Crew Chief: 2nd yr (Rebecca Morris), 1st yr (Travis Kuhlka), pre-vet (Allison Wistrand).

\subsection{Thursday}
\textbf{AM:}

\textbf{PM:} Herd Health Management (623-675): Crew Chief: 2nd yr (Rebecca Morris), 1st yr (Travis Kuhlka), pre-vet (Allison Wistrand).

\subsection{Friday}
\textbf{AM:} 7:30am: Management meeting for the teaching herd management team.

\textbf{PM:} Herd Health Management (623-675): Crew Chief: 2nd yr (Rebecca Morris), 1st yr (Travis Kuhlka), pre-vet (Allison Wistrand).

Posilac injections given to eligible cows.

\subsection{Saturday}
Health Management-623-675 for Crew Chief-2nd yr (Rebecca Morris), 1st yr (Travis Kuhlka), pre-vet (Allison Wistrand).

\subsection{Sunday}
Herd Health Management-623-675 for Crew Chief-2nd yr (Rebecca Morris), 1st yr (Travis Kuhlka), pre-vet (Allison Wistrand).

\subsection{Announcement}
\textbf{Yahoo!} Looks like we're on a role...

On February 12th

Greta gave birth to \textbf{Gina!}

[New Arrivals at the Bookhout facility Pamela, Celeste, and Cecil]

\section{Upcoming Events}

\subsection{Cows and heifers due in the next month}

\begin{table}[h]
\centering
\begin{tabular}{ll}
Cow/Heifer & Due Date \\
Lucy & 2/16 \\
Diane & 2/16 \\
Violet & 2/23 \\
Julie & 2/23 \\
Melody & 3/01 \\
Jessica & 3/01 \\
Katrina & 3/26 \\
Cookie & 4/02 \\
Swash & 4/06 \\
\end{tabular}
\caption{Cows and heifers due in the next month}
\label{table_1}
\end{table}
\begin{figure}[h]
\centering
\includegraphics{figure_1.pdf}
\caption{Non-rewireable fused plug and power cord assembly drawing (Model YP-61/YC-12).}
\label{figure_1}
\end{figure}

\begin{table}[h]
\centering
\begin{tabular}{llll}
NO. & SPECIFICATION & QTY & REMARK \\
1 & H05VV-F 3G 1.0mm$^2$ BLACK & 1PC & \\
2 & YP-61 PVC PLASTIC:60P BLACK & 54g/PC & \\
3 & FRAME: BLACK & 1PC & \\
4 & FUSE LID: BLACK & 1PC & \\
5 & FRAME LID & 1PC & \\
6 & FUSE:10A & 1PC & \\
7 & SLEEVE WHITE & 1PC & \\
8 & YC-12 INNER BODY & 1PC & \\
9 & TER:97740BS-0 & 3PCS & \\
10 & YC-12 PVC PLASTIC:50P BLACK & 18g/PC & \\
11 & MINI TIE:L=130mm BLACK & 1PC & \\
12 & LABEL:135*35mm & 1PC & LABEL-801 \\
13 & ZIP BAG:250X110X0.06mm & 1PC & \\
\end{tabular}
\label{table_1}
\end{table}

Product: Non-rewireable fused plug

Brand Name: YUNG LI

Model: YP-61

Electrical Rating: 10A 250V~

Test Method: IEC 60884-1:2002+A1:2006+A2:2013

Manufacture: YUNG LI CO., LTD.

Type: YP-61/YC-12

Drawing No.: CY-B0212-04

Tolerance: $>0\pm0.30$, $>1.0\pm0.50$, $>10.0\pm1.0$, $>20.0\pm2.0$, Angle: $\pm1^{\circ}$

Material: P.V.C

Unit: mm

Scale: 1:1
Director(es) del documento:

Apellidos completos: Peralta Beltrán
Nombres completos: Pablo Yamir

\section*{Título del documento}
El ciclomontañismo una experiencia significativa Universitaria, en la Universidad de Cundinamarca

\section*{Subtítulo}
(Aplica solo para Tesis, Artículos Científicos, Disertaciones, Objetos Virtuales de Aprendizaje)

\section*{Trabajo para optar al título de}
Aplica para Tesis/Trabajo de Grado/Pasantía

Licenciatura en educación básica con énfasis en educación física recreación y deporte

\section*{Año de edición del documento}
09/06/2017

\section*{Descriptores o palabras claves en español e inglés}
Español:
1. experiencias significativas
2. ciclomontañismo
3. reflexion
4. experiencias vividas
5. contextos
6. sentimientos y emociones

Inglés:
1. Significant experiences
2. montanbike
3. reflection
4. life experiences
5. Contexts
6. Feelings and emotions